FindTrial
Sign In

The effect of protein amount on food for ICU cancer patients

The effect of Protein supply on critical cancer patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-48tw95
Enrollment
Unknown
Registered
2019-09-27
Start date
2019-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle wasting and atrophy, not elsewhere classified

Interventions

High-dose group (128 patients): 2.0 grams of protein / kg pre-ICU actual body weight / day (range from 1.75 to 2.5 grams maximum) will be prescribed. Usual dose group (128 patients): 1.5 grams of prot
Dietary supplement
D12.776.796
H01.671.031.849

Sponsors

Hospital de Câncer de Barretos
Lead Sponsor
Hospital de Câncer de Barretos
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Older than 18 years; patients who remain in the ICU for up to 7 days; use of enteral and / or parenteral nutritional therapy.

Exclusion criteria

Exclusion criteria: Under 18 years old; patients on end-of-life care or withdrawal of life support treatments within 7 days of inclusion; pregnant; contraindication of protein supply by the medical care team; acute or chronic kidney injury; dialysis dependence; acute or chronic liver failure

Design outcomes

Primary

MeasureTime frame
Maintaining Muscle Mass Expected with High Protein Dose Supply—

Secondary

MeasureTime frame
Expected to find optimal protein dose for study patient profile—

Countries

Brazil

Contacts

Public ContactJerusa Toloi

Hospital de Câncer de Barretos

jerusatoloi@gmail.com+55-017-33216600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)